Morning Breakouts

Latest KFF Health News Stories

Ballot Box Abortion Debate Could Knock Manchin, Sinema Off Pedestals

Morning Briefing

The two Democratic senators have repeatedly stood in the way of President Joe Biden’s domestic agenda. But their influence could wane in the next Congress if Democrats perform as strongly in the November elections as they have in recent primaries and special elections.

A Felony With Up To Life In Prison: Texas Abortion Law Takes Effect Today

Morning Briefing

On Tuesday night, a federal judge blocked Biden administration guidance that requires doctors to provide abortions in emergency medical situations — the same guidance that was upheld by a different judge in Idaho.

In Win For White House, Judge Blocks Part Of Strict Idaho Abortion Ban

Morning Briefing

The case centered around the Emergency Medical Treatment and Labor Act, known as EMTALA. Idaho’s abortion law is still scheduled to take effect Thursday, minus the provision that the federal judge said the state cannot enforce for now.

Across US, Thousands Of Inmates Live In Dangerously Hot Prisons

Morning Briefing

In Texas, where temperatures regularly climb into the triple digits, two-thirds of the state’s prisons don’t have air conditioning in living areas, The Texas Tribune reports. Inmates in Missouri and Kansas also must cope with scorching heat.

Study Links Having A Chronic Condition With Later Money Issues

Morning Briefing

Axios says the study “cements the connection” between being healthy and financial stability, with financial hardship like medical debts following diagnoses of serious illnesses. Other medical debt news is reported alongside health industry matters.

Biden Administration May Extend Baby Formula Help For WIC Recipients

Morning Briefing

The current program to aid access to baby formula for low-income parents is due to expire Sept. 30. In other news, experts are pushing the White House to work on lowering policing risks for racial minorities if the Food and Drug Administration bans menthol cigarettes.

Monkeypox Antiviral Drug Tpoxx To Enter Human Testing

Morning Briefing

The drug has been shown to fight monkeypox, but mainly in animal studies. Now, University of Oxford scientists are planning human trials. CIDRAP notes U.S. officials are involved in trials, too. Meanwhile, USA Today explains the Jynneos vaccine side effects.

More Young People Use Weed Than Ever; Some Opioid Abuse Fell Last Year

Morning Briefing

Media outlets cover a new study that shows consumption of marijuana and some hallucinogenic drugs hit records in 2021, while narcotic use other than heroin, Vicodin, and OxyContin were all at record low levels among young adults in 2021.

Republicans Try To Get Suit Opposing Wisconsin Abortion Ban Thrown Out

Morning Briefing

The ban is based on a 173-year-old law, but a lawsuit has challenged it on the grounds it violates a 1985 law permitting abortions before a fetus is viable outside the womb. Other abortion-related news comes from Texas, Indiana, and North Carolina.

Abortion Issue Helps Democrat Win NY Special House Election

Morning Briefing

Reproductive rights were a campaign issue leading up to the Tuesday vote. The outcome from an evenly divided Upstate New York district was watched closely by political experts, looking for signs about how the November elections may play out.

Pfizer’s Covid Shot Shown To Be 73% Effective For The Under-5s

Morning Briefing

Vaccines for younger children began in June, and new data from the makers shows that it is proving effective at preventing covid in this age group, particularly so for babies ages 6 months to 23 months.

Data Shine Light On Hospitalization, Long Covid Risk In Adolescents

Morning Briefing

CIDRAP notes that the condition is “relatively rare” in children and teens. But the Washington Post says about 10% of this age group who were hospitalized with covid were experiencing long covid symptoms three months later. Separately, BA.5 and BA.4.6 are expanding across the U.S.

Next-Gen Covid Booster Shots Expected In September

Morning Briefing

According to reporting from NBC News and other outlets, the FDA plans to authorize boosters from both Pfizer-BioNTech and Moderna around Labor Day. The Washington Post also reports on how prior infections may impact booster shots.

Moderna Asks FDA To Authorize Its Updated Covid Shot

Morning Briefing

Moderna is ready, it says, to ship the new version of its vaccine in September, hence it’s seeking official authorization for the shots, which will target BA.4 and BA.5 subvariants. The FDA request is based on data from a booster targeting an earlier omicron variant rather than new human trials.